Harnessing the power of psychedelic drug therapy: CTV W5

The Canadian Mental Health Association reports that approximately five per cent of Canadians are affected by major depression and more than 4,000 Canadians died by suicide in 2019.

Ketamine appears to be especially promising for people who have not had success treating their depression with conventional monoamine antidepressants. And while ketamine’s antidepressant effects are well documented, therapists at Field Trip Health also aim to maximize the psychedelic qualities of the drug and combine it with psychotherapy.

‍